Department of Ankle and Foot Surgery, IRCCS Galeazzi, via R. Galeazzi 4, 20100, Milan, Italy.
Int Orthop. 2013 May;37(5):839-42. doi: 10.1007/s00264-012-1741-0. Epub 2012 Dec 19.
The purpose of this study was to assess the safety and preliminary clinical results of platelet-rich plasma (PRP) injections for treating chronic plantar fasciitis.
Fourteen consecutive patients with chronic plantar fasciitis receiving three injections of PRP into the plantar fascia were assessed 12 months after the procedure. The modified Roles and Maudsley score and a visual analogue scale (VAS) for pain were used to evaluate the clinical results.
According to criteria of the Roles and Maudsley score, at 12 months of follow-up, results were rated as excellent in nine (64.3 %), good in two (14.3 %), acceptable in two (14.3 %) and poor in one (7.1 %) patient. VAS for pain was significantly decreased from 7.1 ± 1.1 before treatment to 1.9 ± 1.5 at the last follow-up (p < 0.01).
In this single-centre, uncontrolled, prospective, preliminary study, results indicate that treating chronic plantar fasciitis with PRP injections is safe and has the potential to reduce pain.
本研究旨在评估富血小板血浆（PRP）注射治疗慢性足底筋膜炎的安全性和初步临床结果。
连续 14 例慢性足底筋膜炎患者在接受足底筋膜内 3 次 PRP 注射后，在术后 12 个月进行评估。采用改良 Roles 和 Maudsley 评分和疼痛视觉模拟评分（VAS）评估临床结果。
根据 Roles 和 Maudsley 评分标准，在 12 个月的随访中，9 例（64.3%）结果评为优秀，2 例（14.3%）为良好，2 例（14.3%）为可接受，1 例（7.1%）为差。疼痛 VAS 从治疗前的 7.1±1.1 显著降低至最后随访时的 1.9±1.5（p<0.01）。
在这项单中心、非对照、前瞻性、初步研究中，结果表明 PRP 注射治疗慢性足底筋膜炎是安全的，并且有可能减轻疼痛。
